MolNFT v1 · #72537 · protein
Crystal structure of blac-E166A covalently bound with cefuroxime
3NBL · Beta-lactamase: “Crystal structure of blac-E166A covalently bound with cefuroxime”. X-ray diffraction, 1 ligand (DXF), 1 pocket (best druggability 0.58). MolNFT v1 #72537 on GenesisL1: 3D structure, binding sites and pockets in GL1X.
- PDB
- 3NBL
- Type
- protein
- Length
- 261 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase
- EC
- 3.5.2.6
- UniProt
- P0C5C1
- Ligands
- DXF
- Pockets
- 1 · best druggability 0.58
Structure
x-ray diffraction · 1 distinct chain · 46% helix, 16% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase (EC 3.5.2.6) | protein | 261 | 46% helix, 16% strand | P0C5C1 |
Ligands and binding sites
- DXF · (2R)-5-[(carbamoyloxy)methyl]-2-[(1R)-1-{[(2Z)-2-(furan-2-yl)-2-(methoxyimino)acetyl]amino}-2-oxoethyl]-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 236 | 0.58 | 0.79 | 26 | DXF |
Modifications
Observed in the structure: 1 covalent (covalent ligand).
Compared structures
- 3NBL · Crystal Structure of BlaC-E166A covalently bound with Cefuroxime · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0C5C1
- Elsewhere: RCSB PDB 3NBL · PDBe 3NBL · UniProt P0C5C1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.